PA
LH icon

Paralel Advisors’s Labcorp LH Stock Holding History

Paralel Advisors’s Portfolio LH Stock Details LH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-11,489
Closed -$2.67M – 125
2025
Q1 		$2.67M Hold
11,489
– – 0.11% 51
2024
Q4 		$2.63M Buy
11,489
+1,040
+10% +$239K 0.11% 54
2024
Q3 		$2.34M Hold
10,449
– – 0.1% 60
2024
Q2 		$2.13M Buy
10,449
+2,104
+25% +$428K 0.1% 60
2024
Q1 		$1.82M Hold
8,345
– – 0.08% 78
2023
Q4 		$1.9M Hold
8,345
– – 0.1% 74
2023
Q3 		$1.68M Sell
8,345
-1,248
-13% -$263K 0.09% 67
2023
Q2 		$1.99M Buy
9,593
+1,623
+20% +$315K 0.11% 52
2023
Q1 		$1.57M Buy
7,970
+210
+3% +$43.2K 0.09% 66
2022
Q4 		$1.57M Buy
+7,760
New +$1.52M 0.09% 57

Other funds holding LH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
Diamond Hill Capital Management
Diamond Hill Capital Management Columbus, Ohio $16B AUM 4.15% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Paralel Advisors's LH Position: Q2 2025 in Review

Paralel Advisors sold out of Labcorp (LH) in Q2 2025, closing a stake of 11,489 shares — an estimated $2.67M sold.

Paralel Advisors first reported a position in LH in Q4 2022 and held it in 10 quarters. The position peaked at $2.67M in Q1 2025. 973 funds tracked by Wall St. Rank hold LH as of Q2 2025.

  • Paralel Advisors reported no remaining Labcorp position as of Q2 2025 after selling out during the quarter.
  • Paralel Advisors sold 11,489 Labcorp shares in Q2 2025, an estimated $2.67M.
  • Paralel Advisors first reported a position in Labcorp in Q4 2022 and held it in 10 quarters.
  • Paralel Advisors's Labcorp position peaked at $2.67M in Q1 2025.
  • 973 funds tracked by Wall St. Rank held Labcorp as of Q2 2025.

Based on Paralel Advisors's 13F filing for Q2 2025, filed 30 Jul 2025.